WHO highlights scarcity of treatment for epilepsy in low-income countries
Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma.
The findings are published in "Epilepsy, a public health imperative" released by WHO, the International League Against Epilepsy and the International Bureau for Epilepsy.... read more
PAHO report calls for urgent measures to reduce road traffic deaths among children, adolescents and young people
A new report from the Pan American Health Organization (PAHO) reveals that the number of road traffic deaths continues to rise in the Americas, reaching almost 155,000 per year, 11% of the world's total.
The report, "Status of Road Safety in the Region of the Americas", highlights that road traffic injuries are the leading cause of death for children aged 5 to 14 years, and the second highest ... read more
CDC says 2018-19 flu season was odd but not as severe as the previous deadly season
Lasting 21 weeks, the 2018-19 flu season was not only the longest in a decade, it was unusually marked by two separate waves of influenza A sickness, the US Centers for Disease Control and Prevention confirmed Thursday in a new report.
An H1N1 strain dominated during an initial surge between October through mid-February, followed by a groundswell of H3N2 activity beginning in mid-February and lasting through mid-May, the CDC said.... read more
US Suicide Rates Hit Record-High Levels
Suicide rates in the United States have risen significantly over the past 2 decades and are now at the highest level since World War II, federal health officials with the Centers for Disease Control and Prevention said.
New data from the National Center for Health Statistics (NCHS) show the age-adjusted suicide... read more
Biologics in IBD: More Thoughtful Use Could Improve Outcomes
The real-world effects of biologic therapy for inflammatory bowel disease (IBD) do not match the promising outcomes observed in randomized controlled trials, suggests a study.
In a review of outcomes of almost 50,000 patients with IBD between 1995 and 2012, infliximab did not reduce rates of IBD-related hospitalizations or intestinal surgeries.... read more